Catalyst
Key milestones include interim results and final outcomes of the trial, as well as any announcements from the University of Texas Southwestern Medical Center or collaborators.
Humanexa recommends Monitor.
Date
July 19, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.